Use of a New Hybrid Heparin-Bonded Nitinol Ring Stent in the Popliteal Artery: Procedural and Mid-term Clinical and Anatomical Outcomes

CardioVascular and Interventional Radiology

Volumn 38, Issue 4, 2015, Pages 846-854

  Parthipun, Aneeta ^a   Diamantopoulos, Athanasios ^a   Kitrou, Panagiotis ^a   Padayachee, Soundrie ^a   Karunanithy, Narayan ^a   Ahmed, Irfan ^a   Zayed, Hany ^a   Katsanos, Konstantinos ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Critical limb ischemia; Hybrid; In stent restenosis; Occlusion; Popliteal artery; Stenosis; Stent; TIGRIS

Indexed keywords

AGED; AMPUTATION FREE SURVIVAL; ANATOMY; ARTERY OCCLUSION; ARTICLE; CATHETER SHEATH; CLINICAL ARTICLE; CLINICAL TRIAL; DEVICE SAFETY; DOPPLER FLOWMETRY; FEMALE; GUIDE WIRE; HUMAN; HYBRID; HYBRID HEPARIN BONDED NITINOL RING STENT; IN-STENT RESTENOSIS; INTRAVASCULAR CATHETER; KAPLAN MEIER METHOD; MALE; NITINOL STENT; POPLITEAL ARTERY OCCLUSIVE DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL; TREATMENT OUTCOME; VASCULAR PATENCY; ANATOMY AND HISTOLOGY; ARTERIAL OCCLUSIVE DISEASES; FOLLOW UP; INTERVENTIONAL RADIOLOGY; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROSTHESIS DESIGN; RADIOGRAPHY; STENT;

ALLOY; ANTICOAGULANT AGENT; HEPARIN; NITINOL;

AGED; ALLOYS; ANTICOAGULANTS; ARTERIAL OCCLUSIVE DISEASES; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RADIOGRAPHY, INTERVENTIONAL; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84937521431     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-015-1113-4     Document Type: Article

References (27)

1. Diamantopoulos A, Katsanos K. Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol. 2014;31(4):345–52.
2. Katsanos K, Spiliopoulos S, Karunanithy N, Krokidis M, Sabharwal T, Taylor P. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg. 2014;59(4):1123–33 e1128.
3. Katsanos K, Tepe G, Tsetis D, Fanelli F. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Intervent Radiol. 2014;37(3):592–603.
4. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute, Society for Vascular Nursing, Trans Atlantic Inter-Society Consensus, and Vascular Disease Foundation. Circulation. 2006;113(11):e463–654.
5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.
6. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16(3):261–9.
7. Krankenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116(3):285–92.
8. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3(3):267–76.
9. Scheinert D, Werner M, Scheinert S, et al. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv. 2013;6(1):65–71.
10. Hoffmann U, Vetter J, Rainoni L, Leu AJ, Bollinger A. Popliteal artery compression and force of active plantar flexion in young healthy volunteers. J Vasc Surg. 1997;26(2):281–7.
11. Kroger K, Santosa F, Goyen M. Biomechanical incompatibility of popliteal stent placement. J Endovasc Ther. 2004;11(6):686–94.
12. Piorkowski M, Freitas B, Schmidt A, et al. The use of the GORE(R) TIGRIS(R) vascular stent with dual component design in the superficial femoral and popliteal arteries at 6 months. J Cardiovasc Surg (Torino). 2013;54(4):447–53.
13. Mechanical properties of the GORE TIGRIS vascular stent. Available at: http://www.goremedical.com/resources/dam/assets/AR0092-EU2.pdf. Accessed April 2015.
14. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992;18(5):433–40.
15. Lammer J, Bosiers M, Zeller T, et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg. 2011;54(2):394–401.
16. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879–88.
17. Dake MD, Ansel GM, Jaff MR, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. 2013;61(24):2417–27.
18. Diamantopoulos A, Katsanos K. Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol. 2014;31(4):345–52.
19. Scheinert D, Grummt L, Piorkowski M, et al. A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry. J Endovasc Ther. 2011;18(6):745–52.
20. Chang IS, Chee HK, Park SW, et al. The primary patency and fracture rates of self-expandable nitinol stents placed in the popliteal arteries, especially in the P2 and P3 segments, in Korean patients. Korean J Radiol. 2011;12(2):203–9.
21. Piorkowski M, Freitas B, Steiner S, et al. Twelve-month experience with the GORE(R) TIGRIS(R) Vascular Stent in the superficial femoral and popliteal arteries. J Cardiovasc Surg (Torino). 2014;56:89.
22. Goltz JP, Ritter CO, Kellersmann R, Klein D, Hahn D, Kickuth R. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther. 2012;19(3):450–6.
23. Semaan E, Hamburg N, Nasr W, et al. Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty. Vasc Endovascular Surg. 2010;44(1):25–31.
24. Strecker EP, Boos IB, Gottmann D, Vetter S, Haase W. Popliteal artery stenting using flexible tantalum stents. Cardiovasc Intervent Radiol. 2001;24(3):168–75.
25. Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10(7):861–8.
26. Kawarada O, Higashimori A, Noguchi M, et al. Duplex criteria for in-stent restenosis in the superficial femoral artery. Catheter Cardiovasc Interv. 2013;81(4):E199–205.
27. Rastan A, Krankenberg H, Baumgartner I, et al. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial. Circulation. 2013;127(25):2535–41.